FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Propofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | Hospira, Inc. | Aug 17, 2026 | 0409-0010 |
| Propofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | Hospira, Inc. | Aug 17, 2026 | 0409-0501 |
| Propofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | Hospira, Inc. | Aug 17, 2026 | 0409-1511 |
| Hydrocortisone | Hydrocortisone 5 mg/1 | TabletOral | Solco Healthcare LLC | Aug 17, 2026 | 43547-892 |
| Hydrocortisone | Hydrocortisone 10 mg/1 | TabletOral | Solco Healthcare LLC | Aug 17, 2026 | 43547-893 |
| Hydrocortisone | Hydrocortisone 20 mg/1 | TabletOral | Solco Healthcare LLC | Aug 17, 2026 | 43547-894 |
| Phenobarbital | Phenobarbital 15 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-510 |
| Phenobarbital | Phenobarbital 30 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-514 |
| Phenobarbital | Phenobarbital 60 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-515 |
| Phenobarbital | Phenobarbital 100 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-519 |
| Phenobarbital | Phenobarbital 16.2 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-539 |
| Phenobarbital | Phenobarbital 32.4 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-554 |
| Phenobarbital | Phenobarbital 64.8 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-557 |
| Phenobarbital | Phenobarbital 97.2 mg/1 | TabletOral | Chartwell RX, LLC | Aug 17, 2026 | 62135-558 |
| Gabapentin | Gabapentin 200 mg/1 | CapsuleOral | Trifluent Pharma, LLC | Aug 17, 2026 | 73352-231 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Northwind Health Company, LLC | Aug 17, 2026 | 82868-114 |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | Aug 16, 2026 | 0054-0886 |
| Lithium Carbonate | Lithium carbonate 150 mg/1 | Capsule, Gelatin coatedOral | Hikma Pharmaceuticals USA Inc. | Aug 16, 2026 | 0054-0887 |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | Capsule, Gelatin coatedOral | Hikma Pharmaceuticals USA Inc. | Aug 16, 2026 | 0054-0890 |
| Lithium Carbonate | Lithium carbonate 600 mg/1 | Capsule, Gelatin coatedOral | Hikma Pharmaceuticals USA Inc. | Aug 16, 2026 | 0054-0891 |
| Lactulose | Lactulose 10 g/15mL | SolutionOral | American Health Packaging | Aug 16, 2026 | 60687-917 |
| rosuvstatin | Rosuvastatin calcium 5 mg/1 | Tablet, Film coatedOral | Lifestar Pharma LLC | Aug 16, 2026 | 70756-053 |
| rosuvstatin | Rosuvastatin calcium 10 mg/1 | Tablet, Film coatedOral | Lifestar Pharma LLC | Aug 16, 2026 | 70756-054 |
| rosuvstatin | Rosuvastatin calcium 20 mg/1 | Tablet, Film coatedOral | Lifestar Pharma LLC | Aug 16, 2026 | 70756-055 |
| rosuvstatin | Rosuvastatin calcium 40 mg/1 | Tablet, Film coatedOral | Lifestar Pharma LLC | Aug 16, 2026 | 70756-056 |